TABLOID (Aspen Global Inc.)


Welcome to the PulseAid listing for the TABLOID drug offered from Aspen Global Inc.. This Antimetabolite [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aspen Global Inc.
NON-PROPRIETARY NAME: thioguanine
SUBSTANCE NAME: THIOGUANINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimetabolite [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-03-12
END MARKETING DATE: 0000-00-00


TABLOID HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTABLOID from Aspen Global Inc.
LABELER NAME: Aspen Global Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/1)
START MARKETING DATE: 2013-03-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76388-880_f20f28e5-1a12-499b-adbc-8c949d7e1aa1
PRODUCT NDC: 76388-880
APPLICATION NUMBER: NDA012429

Other THIOGUANINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aspen Global Inc.TABLOID